Does TOPOTECAN\TOPOTECAN Cause Malignant neoplasm progression? 22 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Malignant neoplasm progression have been filed in association with TOPOTECAN\TOPOTECAN. This represents 4.3% of all adverse event reports for TOPOTECAN\TOPOTECAN.
22
Reports of Malignant neoplasm progression with TOPOTECAN\TOPOTECAN
4.3%
of all TOPOTECAN\TOPOTECAN reports
10
Deaths
2
Hospitalizations
How Dangerous Is Malignant neoplasm progression From TOPOTECAN\TOPOTECAN?
Of the 22 reports, 10 (45.5%) resulted in death, 2 (9.1%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOPOTECAN\TOPOTECAN. However, 22 reports have been filed with the FAERS database.
What Other Side Effects Does TOPOTECAN\TOPOTECAN Cause?
Disease progression (111)
Neutropenia (44)
Drug resistance (35)
Mucosal inflammation (24)
Bone marrow failure (23)
Bronchospasm (23)
Nausea (20)
Anaemia (18)
Hypertension (18)
Infection (18)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which TOPOTECAN\TOPOTECAN Alternatives Have Lower Malignant neoplasm progression Risk?
TOPOTECAN\TOPOTECAN vs TOPROL
TOPOTECAN\TOPOTECAN vs TOREMIFENE
TOPOTECAN\TOPOTECAN vs TORIPALIMAB
TOPOTECAN\TOPOTECAN vs TORSEMIDE
TOPOTECAN\TOPOTECAN vs TOVIAZ